BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Samson JM, Ravindran Menon D, Smith DE, Baird E, Kitano T, Gao D, Tan AC, Fujita M. Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes. Chem Biol Interact 2019;314:108822. [PMID: 31580832 DOI: 10.1016/j.cbi.2019.108822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Yang Z, Qi F. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy. Mol Biol Rep 2020;47:1435-43. [PMID: 31838656 DOI: 10.1007/s11033-019-05227-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 Peng W, Zhao ZZ, Jiao L, Wu T, Chen H, Zhang CY, Song JJ, Liu TY, Wu LJ, Wang MJ, Chen J, Zhou Y, Ying BW. Prospective study of ALDH1A1 gene polymorphisms associated with antituberculosis drug-induced liver injury in western Chinese Han population. Microbiol Immunol 2021;65:143-53. [PMID: 33527427 DOI: 10.1111/1348-0421.12877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pizzimenti S, Ribero S, Cucci MA, Grattarola M, Monge C, Dianzani C, Barrera G, Muzio G. Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies. Antioxidants (Basel) 2021;10:1942. [PMID: 34943045 DOI: 10.3390/antiox10121942] [Reference Citation Analysis]
4 Nie S, Qian X, Shi M, Li H, Peng C, Ding X, Zhang S, Zhang B, Xu G, Lv Y, Wang L, Friess H, Kong B, Zou X, Shen S. ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose Metabolism. Front Oncol 2020;10:915. [PMID: 32612951 DOI: 10.3389/fonc.2020.00915] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Everts HB, Akuailou EN. Retinoids in Cutaneous Squamous Cell Carcinoma. Nutrients 2021;13:E153. [PMID: 33466372 DOI: 10.3390/nu13010153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lei S, Zhang Y. Integrative analysis identifies key genes related to metastasis and a robust gene-based prognostic signature in uveal melanoma. BMC Med Genomics 2022;15:61. [PMID: 35300699 DOI: 10.1186/s12920-022-01211-1] [Reference Citation Analysis]
7 Zhang C, Zhu X, Hou S, Pan W, Liao W. Functionalization of Nanomaterials for Skin Cancer Theranostics. Front Bioeng Biotechnol 2022;10:887548. [DOI: 10.3389/fbioe.2022.887548] [Reference Citation Analysis]
8 Martinez R 3rd, Huang W, Buck H, Rea S, Defnet AE, Kane MA, Shapiro P. Proteomic Changes in the Monolayer and Spheroid Melanoma Cell Models of Acquired Resistance to BRAF and MEK1/2 Inhibitors. ACS Omega 2022;7:3293-311. [PMID: 35128241 DOI: 10.1021/acsomega.1c05361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Meng L, He X, Zhang X, Zhang X, Wei Y, Wu B, Li W, Li J, Xiao Y. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature. PLoS One 2020;15:e0240331. [PMID: 33031392 DOI: 10.1371/journal.pone.0240331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Shahoumi LA. Oral Cancer Stem Cells: Therapeutic Implications and Challenges. Front Oral Health 2021;2:685236. [PMID: 35048028 DOI: 10.3389/froh.2021.685236] [Reference Citation Analysis]